As KLK3/PSA and KLK4 promote the epithelial–mesenchymal transition (EMT) of prostate cancer cells and their dissemination, KLK4 is also strongly linked to aggressive PCa, whereas knockdown of the KLK4 gene significantly reduces PCa cell proliferation [151,152]. Here, KLK3 is linked to prostate carcinoma.